MYND Life Sciences Inc. (MYNDF)
OTCMKTS · Delayed Price · Currency is USD
0.0081
-0.0129 (-61.43%)
At close: Dec 12, 2025
MYND Life Sciences Market Cap
MYND Life Sciences has a market cap or net worth of $3.77 million as of February 12, 2026. Its market cap has increased by 29.91% in one year.
Market Cap
3.77M
Enterprise Value
5.94M
Revenue
1.00
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since May 26, 2021, MYND Life Sciences's market cap has decreased from 81.52M to 3.77M, a decrease of -95.37%. That is a compound annual growth rate of -54.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 1, 2025 | 3.77M | 13.64% |
| Dec 27, 2024 | 3.32M | 130.13% |
| Dec 22, 2023 | 1.44M | 4.19% |
| Dec 30, 2022 | 1.38M | -86.08% |
| Dec 31, 2021 | 9.94M | -87.80% |
| May 26, 2021 | 81.52M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GPL Holdings | 5.83M |
| Bioxytran | 5.56M |
| LakeShore Biopharma | 5.33M |
| Clearside Biomedical | 5.10M |
| AXIM Biotechnologies | 4.99M |
| Enzon Pharmaceuticals | 4.79M |
| Nymox Pharmaceutical | 4.23M |
| Vaccinex | 3.99M |